The Drug-Induced Respiratory Disease Website
Pericarditis (i.e. pericardial inflammation) is usually heralded by acute mediothoracic chest pain (PMID 10878205). Large effusions can be ANA positive and cause pericardial tamponade. When present as a longterm sequela, pericardial thickening may cause restriction and constriction. See also under Vc, d, g, m and XIIk (PMID 20511488, 23376916)
Publications
Lupus-like symptoms with anti-RNP/Sm and anti-nuclear antibodies positivity: An extremely rare adverse event of dasatinib.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2019 Jul 30;;1078155219863469 — 2019 Jul 30 — 1078155219863469
Occurrence and current management of side effects in chronic myeloid leukemia patients treated frontline with tyrosine kinase inhibitors.
Leukemia research 2013 Jun;37;713-20 — 2013 Jun — 713-20
Latagliata R, Breccia M, Fava C, Stagno F, Tiribelli M, Luciano L, Gozzini A, Gugliotta G, Annunziata M, Cavazzini F, Ferrero D, Musto P, Capodanno I, Iurlo A, Visani G, Crugnola M, Calistri E, Castagnetti F, Vigneri P, Alimena G
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.
Hematological oncology 2013 Jun;31;103-9 — 2013 Jun — 103-9
Extensive pleural and pericardial effusion in chronic myeloid leukemia during treatment with dasatinib at 100 mg or 50 mg daily.
Haematologica 2011 Jan;96;163-6 — 2011 Jan — 163-6
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.
Expert opinion on drug safety 2010 Sep;9;713-21 — 2010 Sep — 713-21
Serosal inflammation (pleural and pericardial effusions) related to tyrosine kinase inhibitors.
Targeted oncology 2009 Apr;4;99-105 — 2009 Apr — 99-105